Speech-Language Pathologists in Luzerne, PA Accepting Medicare
1 Speech-Language Pathologists found. Showing 1 - 1
 Kaitlyn Anna Zaloga, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 140 Main St, Luzerne, PA 18709 Phone: 570-362-2348 |
News Archive
Inability of Mass. to curb health costs could be harbinger for national efforts
Last week, Massachusetts health reform "advocates celebrated a new report showing that, despite the devastating economic slump, the vast majority of Massachusetts residents had not dropped health insurance coverage." But also in the headlines were reports that "a state official called Massachusetts's decision to reject the vast majority of insurer rate hikes a 'train wreck' that would very likely lead to the insolvency of some companies.
GW researcher awarded SFARI grant for autism research
The link between autism and disrupted brain development is an essential part of the puzzle of the disease, and is largely unknown. However, thanks to funding from the Simons Foundation Autism Research Initiative, George Washington University researcher Anthony-Samuel LaMantia, Ph.D. may be able to offer truly integrative and in-depth answers to these key questions in the field of autism research.
Preterm birth and low birth weight are most frequent causes of infant death, study reveals
A study by University of Alabama at Birmingham researchers published April 1, 2013, in the journal Pediatrics showed that increasing numbers of premature and other low birth weight infants are the leading cause for the leveling off of infant mortality and neonatal mortality rates in the United States.
Philadelphia insurer to implement pay-for-performance model
The Philadelphia region's largest health insurer, Independence Blue Cross, will begin a pay-for-performance model that pays physicians more if their patient's health gets better. The program rewards primary care doctors who provide higher quality care at less cost. "A key element of the program rewards doctors who meet standards as so-called patient-centered medical homes.
SSRIs exhibit anti-inflammatory effects and may provide drug development opportunities for RA
A new study found that fluoxetine (Prozac-) and citalopram (Celexa-) treatment significantly inhibited disease progression of collagen-induced arthritis (CIA) in mice. Research led by Sandra Sacre, Ph.D. from the Brighton and Sussex Medical School (BSMS) in the UK studied the anti-arthritic potential of these drugs, known as selective serotonin reuptake inhibitors (SSRIs), most commonly used to treat depression.
› Verified 7 days ago